We have located links that may give you full text access.
Long-term Outcomes of Coarctation Repair via Left Thoracotomy.
Annals of Thoracic Surgery 2018 September 9
BACKGROUND: Optimal surgical approach for repair of coarctation of the aorta (CoA) remains controversial. This study aims to evaluate reintervention rates and its predictors using a strategy of resection with extended end-to-end anastomosis (REEEA) via left thoracotomy.
METHODS: A retrospective analysis was performed for all patients who underwent isolated CoA repair or CoA and simultaneous VSD repair via REEEA between Jan 2000-Dec 2015. Patients with complex congenital heart disease were excluded. Transverse arch hypoplasia was defined as echocardiographic z-score < -2 or by documentation in medical/operative reports. Reintervention was defined as need for balloon angioplasty or reoperation. Hypertension was defined as antihypertensive medication use or blood pressure ≥ 95th percentile.
RESULTS: A total of 251 patients with median age at repair of 14.6 days met inclusion criteria. Repair was by left thoracotomy in 226 (90%). Follow-up data were available for 186/251 patients with median follow-up time of 5.4 years (range, 0.2-15.3), of which 169 (91%) underwent thoracotomy. There were no early deaths or early reoperations. A proximal transverse arch z-score < -4.1 or distal transverse arch z-score of < -2.8 was predictive of repair via sternotomy. Only 4 (2%) patients required reintervention (2 balloon angioplasties, 2 reoperations). Transverse arch hypoplasia was a risk factor for reintervention (p=0.048), but surgical approach was not (p=0.35). Late hypertension was identified in only 33/186 (18%) patients.
CONCLUSIONS: Repair of CoA even with associated transverse arch hypoplasia via REEEA through left thoracotomy has a low mortality, low reintervention rate, and low incidence of late hypertension.
METHODS: A retrospective analysis was performed for all patients who underwent isolated CoA repair or CoA and simultaneous VSD repair via REEEA between Jan 2000-Dec 2015. Patients with complex congenital heart disease were excluded. Transverse arch hypoplasia was defined as echocardiographic z-score < -2 or by documentation in medical/operative reports. Reintervention was defined as need for balloon angioplasty or reoperation. Hypertension was defined as antihypertensive medication use or blood pressure ≥ 95th percentile.
RESULTS: A total of 251 patients with median age at repair of 14.6 days met inclusion criteria. Repair was by left thoracotomy in 226 (90%). Follow-up data were available for 186/251 patients with median follow-up time of 5.4 years (range, 0.2-15.3), of which 169 (91%) underwent thoracotomy. There were no early deaths or early reoperations. A proximal transverse arch z-score < -4.1 or distal transverse arch z-score of < -2.8 was predictive of repair via sternotomy. Only 4 (2%) patients required reintervention (2 balloon angioplasties, 2 reoperations). Transverse arch hypoplasia was a risk factor for reintervention (p=0.048), but surgical approach was not (p=0.35). Late hypertension was identified in only 33/186 (18%) patients.
CONCLUSIONS: Repair of CoA even with associated transverse arch hypoplasia via REEEA through left thoracotomy has a low mortality, low reintervention rate, and low incidence of late hypertension.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app